RN
Robert Nelsen (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in City Therapeutics, Inc. (CTY). The largest single filing was $3.1M of CTY (170,000 sh × $18.00, as filed), executed Oct 19. The median gap between execution and disclosure was 0 days. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
purchases not yet priced
Delay-adjustediThe same average, entered at disclosure dates
–
purchases not yet priced
Filings, ttm
1
1 buys · 0 sells
Median delay
0d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$3.1M
shares × price, as filed
Last traded
Oct 19
Filed Oct 19
Median ADV $30.2M across their filed names
100% of their measured filings could not be priced (delisted or unquoted names). The returns above cover only what still trades.
Open performance→Volume by month
Buys $13.1M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
CTYRecent filings
CTYPURCHASE
City Therapeutics, Inc.
View filing →
$3.1M170,000 sh × $18.00
Exec Oct 19
Filed Oct 19 · 5:37 PM ET PRMEPURCHASE Prime Medicine, Inc. View filing → $10.0M
3,030,300 sh × $3.30
Exec Aug 1 2025
Filed Aug 1 2025 · 7:19 PM ET